Aura Biosciences Cash Flow Statement (2020-2026) | AURA

Cash Flow Statement Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income (Quarter)
-22.95M-11.78M-74.30M-40.96M-59.05M-18.38M-17.47M-18.30M-18.51M-22.13M-19.71M-20.34M-21.04M-26.91M-27.48M-27.02M-26.13M79.67M-33.69M-45.64M
Depreciation and Depletion (Quarter)
0.20M0.20M0.30M0.30M0.30M0.35M0.33M0.30M0.40M0.29M0.31M0.30M0.30M0.30M0.30M0.30M0.30M0.23M0.30M0.30M
Share-based Compensation (Quarter)
0.55M1.30M1.59M1.29M1.71M1.81M1.91M1.93M2.33M2.60M2.91M3.13M2.75M2.94M3.51M3.83M14.60M3.28M19.30M26.20M
Gains from Investment Securities (Quarter)
0.01M0.04M-0.06M
Cash from Operations (Quarter)
-8.69M-12.09M-15.20M-10.63M-10.76M-18.01M-16.41M-14.64M-15.40M-17.39M-24.45M-16.13M-15.27M-23.95M-23.36M-20.77M-20.14M-20.43M-29.89M-32.50M
Depreciation, Depletion & Amortization
Depreciation & Amortization (CF) (Quarter)
0.20M0.20M0.30M0.30M0.30M0.35M0.33M0.30M0.40M0.29M0.31M0.30M0.30M0.30M0.30M0.30M0.30M0.23M0.30M0.30M
Change in Working Capital
Change in Account Payables (Quarter)
-0.72M0.16M-0.76M-0.76M0.84M1.02M-1.88M-0.50M0.89M0.46M0.02M-0.54M0.69M0.31M-0.30M-0.72M0.60M-0.43M1.02M-0.33M
Change in Accured Expenses (Quarter)
1.11M0.85M-1.83M1.43M1.34M-0.70M-0.51M1.27M1.03M1.51M-2.90M1.35M3.14M-0.02M-2.48M3.38M3.35M-0.12M-2.75M3.17M
Investing Activities
Capital Expenditures (Quarter)
0.57M-0.92M0.31M0.12M0.31M-0.56M0.11M-0.10M0.25M-0.17M0.12M-0.19M-0.42M1.74M0.23M0.04M0.18M0.05M0.57M
Change in Acquisitions & Divestments (Quarter)
18.00M32.01M22.08M21.60M21.72M55.00M99.18M30.00M30.00M30.00M30.00M30.00M55.00M30.00M
Cash from Investing Activities (Quarter)
-0.57M-0.82M-25.50M-43.44M17.95M-16.88M-66.88M21.41M21.63M-90.12M9.40M19.84M9.89M29.70M29.81M19.98M-44.02M29.82M54.90M-226.03M
Financing Activities
Other financing activities (Quarter)
0.02M0.04M0.02M0.31M0.10M0.14M-0.09M0.07M0.16M-0.06M0.78M0.54M14.16M-13.15M0.12M21.26M
Cash from Financing Activities (Quarter)
-1.12M80.14M0.02M0.31M0.10M95.20M0.20M2.48M1.63M92.98M0.25M0.08M0.72M0.54M0.10M69.93M4.36M2.77M0.30M241.75M
Change in Capital Stock
Net Equity Issued and Repurchased (Quarter)
73.26M-73.26M1.20M3.90M-39.82M
Additional items
Exchange Rate Effect (Quarter)
-0.02M0.01M-0.01M-0.16M-0.03M-0.17M
Change in Cash (Quarter)
-10.38M67.24M-40.68M-53.76M7.29M60.31M-83.09M9.24M7.85M-14.52M-14.80M3.80M-4.67M6.29M6.55M69.13M-59.80M12.12M25.30M-16.78M
Free Cash Flow (Quarter)
-9.26M-11.17M-15.51M-10.74M-11.07M-17.46M-16.52M-14.55M-15.65M-17.22M-24.57M-15.94M-14.85M-25.69M-23.36M-21.00M-20.19M-20.60M-29.94M-33.07M
Net Cash Flow (Quarter)
-10.38M67.24M-40.68M-53.76M7.29M60.31M-83.09M9.24M7.85M-14.52M-14.80M3.80M-4.67M6.29M6.55M69.13M-59.80M12.16M25.30M-16.78M